Jennifer Castro

Jennifer Castro

Board member and Co-founder

About

19+ years of experience advancing multiple oncology precision medicine programs from target validation through IND and into early clinical development: ·  First-in-class DHX9 inhibitor, ATX-559 for molecularly defined solid tumors in Phase 1 (Project leader, Accent)·  FDA-approved REZLIDHIA (Oluastenib, IDH1 mutant inhibitor) for relapsed/refractory AML (Forma) ·  CBP/p300 inhibitor Pocenbrodib (FT-7051) currently in Phase 2 for metastatic CRPC (Forma) ·  FT-4101 a FASN inhibitor, discontinued in Phase 1 for treatment of NASH (Forma) ·  FGFR inhibitor Derazanitinib currently in Phase 2 for intrahepatic cholangiocarcinoma (Arqule) Excels at cross-functional project leadership, driving translational and clinical assay development and strategy, building high impact partnerships across industry and academia, and contributing to the broader scientific community.

Country

United States

City

Billerica

Industry

Biotechnology

Skill

Target Validation, Clinical Trials, People Management, Project Leadership, Collaborative Leadership, Networking, Webinar Management, Epigenetics, Angiogenesis, Translational Research, Drug Discovery, Biomarker Discovery, Oncology, Molecular Biology, Cell Biology, Assay Development, Drug Development, Cell, Cell Culture, Biotechnology

Experience

Boston Epigenetics Society

Board member and Co-founder

Boston Epigenetics Society

2021-10 - Present · 5 yrs

Boston, Massachusetts, United States

Accent Therapeutics, Inc.

Director of Translational and Discovery Biology

Accent Therapeutics, Inc.

LinkedIn
2025-1 - 2026-1 · 1 yr 1 mo

United States

Accent Therapeutics, Inc.

Associate Director

Accent Therapeutics, Inc.

LinkedIn
2022-12 - 2025-1 · 2 yrs 2 mos

Lexington, Massachusetts, United States

Accent Therapeutics, Inc.

Principal Scientist

Accent Therapeutics, Inc.

LinkedIn
2021-8 - 2022-12 · 1 yr 5 mos

Lexington, Massachusetts, United States

Accent Therapeutics, Inc.

Senior Scientist

Accent Therapeutics, Inc.

LinkedIn
2020-7 - 2021-8 · 1 yr 2 mos

Lexington, Massachusetts, United States

Accent Therapeutics, Inc.

Scientist

Accent Therapeutics, Inc.

LinkedIn
2019-1 - 2020-7 · 1 yr 7 mos

Lexington, Massachusetts

Forma Therapeutics (Now Novo Nordisk)

Scientist Discovery Biology

Forma Therapeutics (Now Novo Nordisk)

LinkedIn
2011-9 - 2018-12 · 7 yrs 4 mos

Watertown, MA

ArQule

Research Scientist II

ArQule

2007-10 - 2011-9 · 4 yrs

Woburn, Massachusetts, United States

BD

Research Associate

BD

LinkedIn
2005-10 - 2007-9 · 2 yrs
Tufts-New England Medical Center

Research Assistant III

Tufts-New England Medical Center

2003-5 - 2005-10 · 2 yrs 6 mos

Molecular Cardiology Research Center

Education

University of New Hampshire

University of New Hampshire

LinkedIn

Biology: Molecular, Cellular & Developmental

1999 - 2003 · 4 yrs
Harvard Extension School

Harvard Extension School

LinkedIn

Biotechnology

Jennifer Castro's Contact Information

Email

******@***.com

Phone

(**) *** ****

Find the Right Leads
Find Verified Contact Data

Try with: Jensen Huang @ nvidia.com Click to autofill
LeadContact awards, five-star ratings, and GDPR compliance badges

What LeadContact does well

Find verified emails, phone numbers, and decision-makers with 98% accuracy.

Find Leads

Find Leads

Find the right people by company, role, industry, location, and more.

925M+ professional profiles

Find Leads
Find Emails

Find Emails

Access verified email addresses for your target contacts.

657M+ emails

Find Emails
Find Phone Numbers

Find Phone Numbers

Get cross-validated phone data from multiple top sources.

239M+ phone numbers

Find Phone Numbers

More Accurate. Lower Cost.

Find contact data in 1 tool with 98% accuracy

LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.

LeadContact Logo
Competitor Tools

All these = $289 per month

Great conversations start with the right contact.

It’s time to find yours.